Notify me when GILEAD SCIENCES, INC. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 9 | $1,791,467,184 | +$58,775,552 | -$5,069,461 | +$53,706,091 | GLPG, ACLX, RCUS, ASMB, MRUS | 13F-HR | 13 Nov 2025, 16:44 |
| Q2 2025 | 14 | $1,280,204,668 | $0 | -$2,420,420 | -$2,420,420 | GLPG, ACLX, RCUS, ASMB, TNGX | 13F-HR | 14 Aug 2025, 10:58 |
| Q1 2025 | 14 | $1,181,331,731 | +$16,512,425 | -$9,131,340 | +$7,381,085 | ACLX, GLPG, RCUS, ASMB, MRUS | 13F-HR | 13 May 2025, 16:15 |
| Q4 2024 | 16 | $1,551,148,266 | $0 | $0 | $0 | ACLX, GLPG, RCUS, ASMB, MRUS | 13F-HR | 13 Feb 2025, 16:14 |